Company Filing History:
2 out of 817 
2 out of 547 
2 out of 162 
Years Active: 2025
Title: Kate Eshelman: Innovator in Biofilm Research
Introduction
Kate Eshelman is a prominent inventor based in Alexandria, VA (US). She has made significant contributions to the field of biofilm research, focusing on methods to inhibit biofilm formation and treat bacterial infections. With a total of 2 patents, her work is paving the way for advancements in medical treatments.
Latest Patents
Eshelman's latest patents include innovative methods for using small molecule inhibitors of the BfrB:Bfd interaction in biofilms. The first patent discloses methods of inhibiting biofilm formation, increasing bacteriocidal activity within a biofilm, treating bacteria within a biofilm, or remediating a biofilm in or on a subject. This involves administering an effective amount of a compound according to a specific formula. The second patent provides compounds of the same formula and related methods for treating bacterial infections, as well as methods for inhibiting the interaction of a bacterioferritin and a bacterioferritin-associated ferredoxin.
Career Highlights
Throughout her career, Eshelman has worked with esteemed institutions such as Louisiana State University and Agricultural & Mechanical College and the University of Kansas. Her research has garnered attention for its potential impact on public health and infection control.
Collaborations
Eshelman has collaborated with notable colleagues, including Mario Rivera and Huili Yao. Their combined expertise has contributed to the advancement of research in biofilm inhibition and treatment.
Conclusion
Kate Eshelman is a trailblazer in the field of biofilm research, with her innovative patents and collaborations highlighting her commitment to improving health outcomes. Her work continues to inspire future advancements in the treatment of bacterial infections.